Journal of Infectious Diseases & Preventive Medicine
Open Access

I.I. Mechnikov Research Institute for Vaccines and Sera, Moscow, Russian Federation

Biography

I.I. Mechnikov Research Institute for Vaccines and Sera, Moscow, Russian Federation Dr. Nataliya A. Mikhailova is a distinguished immunologist and researcher at the I.I. Mechnikov Research Institute for Vaccines and Sera in Moscow, Russia. Her work primarily focuses on immunology, vaccine development, and the study of infectious diseases. Research Focus: Dr. Mikhailova's research centers on: Development and evaluation of vaccines against various infectious agents. Immunological responses to vaccines and pathogens. Characterization of antibodies and their role in disease prevention.Dr. Mikhailova is affiliated with the I.I. Mechnikov Research Institute for Vaccines and Sera, contributing to its research initiatives and academic programs in immunology and vaccine development

Publications

• Research Article   
  TetraFluBet: A Tetravalent Influenza Vaccine Enhanced with Natural Betulin Adjuvant
  Author(s): Irina Tcymbarevich, Anna Krasheninnikova, Maria Sukhova, Aleksandr Ivanov, Marina Stukova, Ekaterina Romanovskaya-Romanko, Nataliya Mikhailova, Anton Belkin, Olga Belyakova, Alevtina Nicolaeva and Igor Krasilnikov*
  
  Influenza is well-known to have a considerable influence on the healthcare system; therefore, vaccination plays a significant role in dealing with severe consequences. Close attention is paid to the development of tetravalent adjuvanted vaccines containing antigens of two influenzas A subtypes (H1N1, H3N2) and two influenza B subtypes (Victoria, Yamagata) to increase the effectiveness of influenza prevention. In this work, we present the results of an animal study of an innovative subunit tetravalent candidate influenza vaccine with the addition of betulin as an adjuvant, TetraFluBet. The study was conducted using female BALB/c mice, male and female mongrel rats, and guinea pigs. TetraFluBet was injected intraperitoneally twice in a 14-day interval prior to intranasal infection with 100LD50. Sub-chronic toxicity was assessed by immunohistochemistry of extracted organs and by hematolog.. View More»
  DOI: 10.35841/2329-8731.24.12.371

  Abstract HTML PDF

Other relevant publications from this author

• https://doaj.org/article/6c3e84e7735946cfb8d648d437560eae?utm_source=chatgpt.com

  https://link.springer.com/article/10.1007/s10517-020-04736-6?utm_source=chatgpt.com